Blog
RSS FeedPosted by Michael Wonder on 13 Oct 2023
2024 Medicare Parts A & B premiums and deductibles
12 October 2023 - Today, the CMS released the 2024 premiums, deductibles, and coinsurance amounts for the Medicare Part A ...
Posted by Michael Wonder on 07 Dec 2022
An innovation surcharge to fund the repurposing of generic drugs
10 November 2022 - The use of generic drugs continues to increase, generating substantial savings for purchasers and improving affordable access ...
Posted by Michael Wonder on 15 Sep 2022
FDA’s drug industry fees fuel concerns over influence
15 September 2022 - The pharmaceutical industry finances about 75% of the agency’s drug division, through a controversial program that ...
Posted by Michael Wonder on 23 Mar 2021
Indian cancer drug manufacturer to pay $50 million for concealing and destroying records in advance of FDA inspection
23 March 2021 - Indian drug manufacturer Fresenius Kabi Oncology was sentenced to pay $50 million in fines and forfeiture ...
Posted by Michael Wonder on 04 Jun 2020
FDA re-evaluates user fees for biosimilar reviews
4 June 2020 - Even before the pandemic, the FDA was having trouble estimating its resource needs for biosimilar application reviews. ...
Posted by Michael Wonder on 16 Apr 2020
COVID-19 update: FDA continues user-fee related reviews
16 April 2020 - The U.S. FDA's User Fee programs help us fulfil our mission to protect public health while ...
Posted by Michael Wonder on 15 Apr 2020
Novo Nordisk offers free 90 day insulin supply to people experiencing financial hardship due to COVID-19
14 April 2020 - People with diabetes using Novo Nordisk insulin who have lost health insurance coverage because of a ...
Posted by Michael Wonder on 01 Oct 2019
Fees for redeeming priority review vouchers fall to all-time low in FY2020
30 September 2019 - The US FDA on Friday announced the fees for using a priority review voucher to speed ...
Posted by Michael Wonder on 16 May 2019
Instalment payments could be used across gene therapy space, Spark CEO says
16 May 2019 - In a fireside chat at the recently concluded Veeva Summit in Philadelphia, Jeff Marrazzo said payment over ...
Posted by Michael Wonder on 07 Mar 2019
Gottlieb: drug rebates not benefiting sicker patients
6 March 2019 - Food and Drug Administration (FDA) Commissioner Scott Gottlieb said Wednesday that drug discounts known as rebates ...
Posted by Michael Wonder on 26 Feb 2019
A small drug maker settles charges for paying others to submit its FDA applications
26 February 2019 - A small drug maker was fined $4 million for striking deals with two tiny companies to ...
Posted by Michael Wonder on 17 Oct 2018
Extending the user fee approach to pharmaceuticals
16 October 2018 - A central theme in economics is that people who benefit the most from a good or service ...
Posted by Michael Wonder on 23 Sep 2018
FDA proposes stiff fines for failing to report clinical trials
20 September 2018 - Pharmaceutical companies could face penalties of up to US$10,000 per day. ...
Posted by Michael Wonder on 07 Apr 2018
Why Trump’s tariffs could raise the cost of a hip replacement
6 April 2018 - Pacemakers and artificial joints. Defibrillators. Dental fillings. Birth-control pills and vaccines. All are made in China, ...
Posted by Michael Wonder on 17 Oct 2017
Generic drug user fees reauthorisation: a victory for public health
17 October 2017 - We marked an important milestone in the U.S. generic drug program on 1 October 2017 – the ...